Part 12, Reference for Chapter 139: Kaposi Sarcoma
Skip chapter table of contents and go to main content
- 1 Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 2010;10(10):707–19.Cross Ref linkPubmed link , , .
- 2 Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997;336(14):988–93.Cross Ref linkPubmed link , , , et al.
- 3 Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma‐associated herpesvirus‐induced cell reprogramming. Trends Cell Biol 2013;23(9):421–32.Cross Ref linkPubmed link , , .
- 4 Classic Kaposi's sarcoma in Italy, 1985–1998. Br J Cancer 2005;92(1):188–93.Cross Ref linkPubmed link , , , et al.
- 5 Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. Int J Cancer 2001;91(4):588–91.Cross Ref linkPubmed link , , , et al.
- 6 Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 1994;69(2):333–6.Cross Ref linkPubmed link , , , et al.
- 7 Classic Kaposi's sarcoma in southern Sardinia, Italy. Br J Cancer 2004;91(7):1261–2.Cross Ref linkPubmed link , , , et al.
- 8 Variability in the incidence of classic Kaposi's sarcoma in the Veneto region, northern Italy. Tumori 2003;89(2):122–4.Pubmed link , , , et al.
- 9 An overview of classic Kaposi's sarcoma in Greece. Adv Exp Med Biol 1999;455:503–6.Cross Ref linkPubmed link , , .
- 10 Classic Kaposi's sarcoma in Greece: a clinico‐epidemiological profile. Int J Dermatol 1997;36(10):735–40.Cross Ref linkPubmed link , , , et al.
- 11 Molecular genetics of Kaposi's sarcoma‐associated herpesvirus (human herpesvirus‐8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 2003;67(2):175–212, table of contents.Cross Ref linkPubmed link , , , , .
- 12 Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002;2(6):344–52.Cross Ref linkPubmed link , , , et al.
- 13 Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002;2(5):281–92.Cross Ref linkPubmed link , , , et al.
- 14 Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr 1995;8(1):96–100. , , , .
- 15 Kaposi's sarcoma in Uganda Africans. Acta Pathol Microbiol Scand 1963:161(Suppl.):1–71. .
- 16 L'angiosarcomatose de Kaposi au Congo belge et au Ruanda‐Urundi. [Kaposi's angiosarcomatosis in the Belgian Congo and Ruanda‐Urundi.] Ann Soc Belg Med Trop (1920) 1957;37(2):295–308. .
- 17 Further experience with Kaposi's sarcoma in Uganda. Br J Cancer 1986;53(4):497–500.Cross Ref linkPubmed link , , , , , .
- 18 Kaposi's sarcoma in different populations in South Africa. S Afr Med J 1987;71(10):615–19.Pubmed link , .
- 19 Endemic African Kaposi's sarcoma: clinical and therapeutic implications. 10‐year experience in the Johannesburg Hospital (1980–1990). Oncology 1994;51(1):63–9.Cross Ref linkPubmed link , , , , , .
- 20 Risk factors for Kaposi's sarcoma: a case‐control study of HIV‐seronegative people in Uganda. Int J Cancer 2003;103(2):233–40.Cross Ref linkPubmed link , , , et al.
- 21 The clonality of tumor‐infiltrating lymphocytes in African Kaposi's sarcoma. J Cutan Pathol 2001;28(4):200–5.Cross Ref linkPubmed link , , , , .
- 22 Human herpesvirus‐8 latent nuclear antigen‐1 expression in endemic Kaposi sarcoma: an immunohistochemical study of 16 cases. Am J Surg Pathol 2003;27(12):1546–50.Cross Ref linkPubmed link , , .
- 23 Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 1993;2(6):339–43.Pubmed link .
- 24 Kaposi's sarcoma in transplant recipients. Transplantation 1997;64(5):669–73.Cross Ref linkPubmed link .
- 25 Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1979;27(1):8–11.Cross Ref linkPubmed link .
- 26 Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 1994;14(2):121–6.Cross Ref linkPubmed link , , , , .
- 27 Kaposi's sarcoma post renal transplantation. Aust NZ J Med 1994;24(6):722–3.Cross Ref link , , , .
- 28 Maladie de Kaposi des transplantes cardiaques. [Kaposi's sarcoma in after heart transplantation.] Ann Dermatol Venereol 1991;118(11):864–6.Pubmed link , , , .
- 29 Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation 1998;65(4):583–5.Cross Ref linkPubmed link , , , et al.
- 30 Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients. Artif Organs 2004;28(6):595–9.Cross Ref linkPubmed link , , , et al.
- 31 Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol 2006;16(5):553–7.Pubmed link , , , et al.
- 32 Increased seroprevalence of human herpes virus‐8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant 2005;20(11):2532–6.Cross Ref linkPubmed link , , , et al.
- 33 The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000;27(4):390–401.Pubmed link .
- 34 A comparison of regimens based on non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. Aids 2003;17(11):F17–22.Cross Ref linkPubmed link , , , et al.
- 35 Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998;338(14):948–54.Cross Ref linkPubmed link , , , , , .
- 36 Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol 2008;59(2):179–206; quiz 7–8.Cross Ref linkPubmed link , , , .
- 37 AIDS‐related Kaposi sarcoma: the role of local therapy for a systemic disease. Arch Dermatol 2000;136(12):1554–6.Pubmed link .
- 38 The enigmas of Kaposi's sarcoma. Science 1998;282(5395):1837–9.Cross Ref linkPubmed link .
- 39 The nature of hyaline (eosinophilic) globules and vascular slits of Kaposi's sarcoma. Am J Dermatopathol 1990;12(3):256–67.Cross Ref linkPubmed link , , .
- 40 Endothelial cell markers CD31, CD34, and BNH9 antibody to H‐ and Y‐antigens – evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7(1):82–90.Pubmed link , , .
- 41 CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. J Cutan Pathol 1995;22(3):215–22.Cross Ref linkPubmed link , , , et al.
- 42 D2‐40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 2005;18(11):1454–60.Cross Ref linkPubmed link , , , , , .
- 43 Expression of D2‐40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 2005;46(4):396–402.Cross Ref linkPubmed link .
- 44 Immunostaining for human herpesvirus 8 latent nuclear antigen‐1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol 2004;121(3):335–42.Cross Ref linkPubmed link , , , , , .
- 45 Immunohistochemical detection of the human herpes virus 8 (HHV8) latent nuclear antigen‐1 in Kaposi's sarcoma. Pathology 2003;35(5):448–50.Cross Ref linkPubmed link , , .
- 46 Identification of herpesvirus‐like DNA sequences in AIDS‐associated Kaposi's sarcoma. Science 1994;266(5192):1865–9.Cross Ref linkPubmed link , , , et al.
- 47 Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother‐child pairs with KS. J Infect Dis 1998;178(6):1787–90.Cross Ref linkPubmed link , , , et al.
- 48 Seroepidemiology and molecular epidemiology of Kaposi's sarcoma‐associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 2001;93(3):194–202.Cross Ref linkPubmed link , , , et al.
- 49 Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000;343(19):1369–77.Cross Ref linkPubmed link , , , et al.
- 50 p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999;402(6764):889–94.Pubmed link , , , .
- 51 Kaposi's sarcoma‐associated herpesvirus‐encoded latency‐associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J Virol 2006;80(2):697–709.Cross Ref linkPubmed link , .
- 52 The latent nuclear antigen of Kaposi sarcoma‐associated herpesvirus targets the retinoblastoma‐E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 2000;6(10):1121–7.Cross Ref linkPubmed link , , .
- 53 The cyclin encoded by Kaposi's sarcoma‐associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 1997;71(6):4193–8.Pubmed link , , , et al.
- 54 Kaposi's sarcoma‐associated herpesvirus‐encoded v‐cyclin triggers apoptosis in cells with high levels of cyclin‐dependent kinase 6. Cancer Res 1999;59(19):4984–9.Pubmed link , , , et al.
- 55 The apoptotic v‐cyclin‐CDK6 complex phosphorylates and inactivates Bcl‐2. Nat Cell Biol 2000;2(11):819–25.Cross Ref linkPubmed link , , , , , .
- 56 The human herpes virus 8‐encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem 2002;277(16):13745–51.Cross Ref linkPubmed link , , , , , .
- 57 Kaposi's sarcoma‐associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 2005;102(15):5570–5.Cross Ref linkPubmed link , , , , , .
- 58 Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies. Clin Dermatol 2013;31(4):413–22.Cross Ref linkPubmed link , , , , , .
- 59 Kaposi sarcoma herpesvirus‐induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 2004;36(7):687–93.Cross Ref linkPubmed link , , , et al.
- 60 The KSHV viral IL‐6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. Virology 2012;428(2):112–20.Cross Ref linkPubmed link , , , , , .
- 61 Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma‐associated herpesvirus. Nat Genet 2004;36(7):683–5.Cross Ref linkPubmed link , , , et al.
- 62 Kaposi's sarcoma‐associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology 2004;328(1):7–18.Cross Ref linkPubmed link , , .
- 63 Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med 2013;210(9):1743–59.Cross Ref linkPubmed link , , , et al.
- 64 Soil silicates and Kaposi's sarcoma in Sardinia. Lancet 1995;346(8987):1436–7.Cross Ref linkPubmed link , , .
- 65 Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 1993;342(8883):1348–51.Cross Ref linkPubmed link .
- 66 Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993;28(3):371–95.Cross Ref linkPubmed link , , , .
- 67 Patch stage Kaposi's sarcoma. J Am Acad Dermatol 1980;2(6):509–12.Cross Ref linkPubmed link , , .
- 68 Clinical aspects of Kaposi's sarcoma. Curr Opin Oncol 1992;4(5):867–74.Cross Ref linkPubmed link , .
- 69 Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 1993;54(1):26–36.Cross Ref linkPubmed link , , , .
- 70 Kaposi's sarcoma in East African children: a report of 51 cases. J Pathol 1970;100(3):187–99.Cross Ref linkPubmed link , , , .
- 71 Clinical aspects of epidemic Kaposi's sarcoma. Cancer Surv 1991;10:39–52.Pubmed link , .
- 72 Kaposi's sarcoma and the acquired immunodeficiency syndrome. Med Clin N Am 1986;70(3):665–75.Pubmed link .
- 73 Leprosy and Kaposi sarcoma presenting as an immune reconstitution inflammatory syndrome in a patient with AIDS. J Am Acad Dermatol 2009;61(3):516–18.Cross Ref linkPubmed link , , , et al.
- 74 Oral Kaposi sarcoma: a case of immune reconstitution inflammatory syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108(1):70–5.Cross Ref linkPubmed link , , , .
- 75 AIDS‐related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 1997;15(9):3085–92.Pubmed link , , .
- 76 Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. Aids 2008;22(9):1019–28.Cross Ref linkPubmed link , , , et al.
- 77 AIDS‐related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the HAART era – the Italian Cooperative Group on AIDS and Tumors and the Italian cohort of patients naive from antiretrovirals. J Clin Oncol 2003;21(15):2876–82.Cross Ref linkPubmed link , , , et al.
- 78 Prospective stage‐stratified approach to AIDS‐related Kaposi's sarcoma. J Clin Oncol 2014;32(5):409–14.Cross Ref linkPubmed link , , , et al.
- 79 Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 1987;14(2 Suppl. 3):13–18.Pubmed link .
- 80 Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol 2003;13(1):83–6.Pubmed link , , , .
- 81 Kaposi's sarcoma: a new staging classification. Cancer Treat Rep 1983;67(6):531–4.Pubmed link , , .
- 82 Moving towards a uniform staging for human immunodeficiency virus‐associated Kaposi's sarcoma. J Clin Oncol 1989;7(9):1184–5.Pubmed link .
- 83 KSHV/HHV8‐associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma. J Cutan Pathol 2006;33(Suppl. 2):46–51.Cross Ref linkPubmed link , , , et al.
- 84 KSHV/HHV‐8 associated Kaposi's sarcoma in lymph nodes concurrent with Epstein‐Barr virus associated Hodgkin lymphoma. J Clin Pathol 2005;58(6):626–8.Cross Ref linkPubmed link .
- 85 Kaposi's sarcoma‐associated herpesvirus/human herpesvirus type 8‐positive solid lymphomas: a tissue‐based variant of primary effusion lymphoma. J Mol Diagn 2005;7(1):17–27.Cross Ref linkPubmed link , , , et al.
- 86 Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer 1980;45(6):1472–9.Cross Ref linkPubmed link , , , , .
- 87 Immunoblastic lymphoma in persons with AIDS‐associated Kaposi's sarcoma: a role for Kaposi's sarcoma‐associated herpesvirus. Mod Pathol 2003;16(5):424–9.Cross Ref linkPubmed link , , , et al.
- 88 Kaposi's sarcoma‐associated herpesvirus‐like DNA sequences in multicentric Castleman's disease. Blood 1995;86(4):1276–80.Pubmed link , , , et al.
- 89 Kaposi's sarcoma‐associated herpesvirus‐like DNA sequences in AIDS‐related body‐cavity‐based lymphomas. N Engl J Med 1995;332(18):1186–91.Cross Ref linkPubmed link , , , , .
- 90 Kaposi's sarcoma and acquired immunodeficiency syndrome. Postmortem findings in twenty‐four cases. J Am Acad Dermatol 1987;16(2 Pt 1):319–25.Cross Ref linkPubmed link , , .
- 91 Gastroscopic findings in Mediterranean Kaposi's sarcoma (non‐AIDS). Gastrointest Endosc 1995;42(4):336–9.Cross Ref linkPubmed link , , , , .
- 92 Endoscopic examination in Kaposi's sarcoma. J Eur Acad Dermatol Venereol 2000;14(3):225–6.Cross Ref linkPubmed link , , .
- 93 Studies in Kaposi's sarcoma. Postmortem findings and disease patterns in women. Cancer 1972;30(3):854–67.Cross Ref linkPubmed link .
- 94 Visceral Kaposi's sarcoma. Arch Pathol 1960;70:740–6.Pubmed link .
- 95 Kaposi sarcoma, with emphasis on the internal manifestations. Arch Dermatol 1974;110(1):115–18.Cross Ref linkPubmed link , , .
- 96 The diagnostic challenge of pulmonary Kaposi's sarcoma with pulmonary tuberculosis in a renal transplant recipient: a case report. Transplantation 2001;71(10):1488–91.Cross Ref linkPubmed link , , , et al.
- 97 The diagnostic challenge and management of pulmonary Kaposi's sarcoma in renal transplant recipients. Saudi Med J 2001;22(12):1061–4.Pubmed link , , .
- 98 Primary Kaposi's sarcoma of the ileum presenting as massive rectal bleeding. Am J Gastroenterol 1987;82(3):276–7.Pubmed link , , , , .
- 99 Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol 2013;68(2):313–31.Cross Ref linkPubmed link , , .
- 100 Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy. J Natl Med Assoc 2006;98(7):1136–9.Pubmed link , , , et al.
- 101 Intralesional vincristine as first‐line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients. Br J Dermatol 2010;162(4):854–9.Cross Ref linkPubmed link , , , , , .
- 102 Intralesional human leukocyte interferon treatment alone or associated with IL‐2 in non‐AIDS related Kaposi's sarcoma. J Dermatol 1992;19(1):35–9.Cross Ref linkPubmed link , , , .
- 103 The therapeutic effect of intralesional interferon in classical Kaposi's sarcoma. Br J Dermatol 1993;129(5):590–3.Cross Ref linkPubmed link , , , , , .
- 104 Imiquimod 5% cream for treatment of HIV‐negative Kaposi's sarcoma skin lesions: a phase I to II, open‐label trial in 17 patients. J Am Acad Dermatol 2008;58(4):585–91.Cross Ref linkPubmed link , , , et al.
- 105 Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. Aids 2008;22(8):937–45.Cross Ref linkPubmed link , , , , , .
- 106 Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment. Arch Dermatol 2008;144(5):692–3.Pubmed link , , , , .
- 107 A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient. Ren Fail 2007;29(1):103–5.Cross Ref linkPubmed link , , , et al.
- 108 Reccurence of Kaposi's sarcoma after increased exposure to sirolimus. Int Immunopharmacol 2006;6(13–14):2018–22.Cross Ref linkPubmed link , , .
- 109 Investigational agents for treatment of AIDS‐related Kaposi's sarcoma. Expert Opin Invest Drugs 2007;16(4):495–504.Cross Ref link , , , .
- 110 Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 2004;77(5):760–2.Cross Ref linkPubmed link , , .
- 111 Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine. Cancer 1994;74(10):2873–8.Cross Ref linkPubmed link , , , et al.
- 112 Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma. J Eur Acad Dermatol Venereol 2006;20(9):1090–4.Cross Ref linkPubmed link , , , et al.
- 113 Oral etoposide for Kaposi's Mediterranean sarcoma. Dermatologica 1988;177(6):365–9.Cross Ref linkPubmed link , , , , .
- 114 Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases. Br J Dermatol 2008;158(6):1339–44.Cross Ref linkPubmed link , , , et al.
- 115 Vinorelbine therapy for Kaposi's sarcoma in a kidney transplant patient. Dermatology 1997;194(3):281–3.Cross Ref linkPubmed link , , , , .
- 116 Liposomal pegylated doxorubicin versus low‐dose recombinant interferon alfa‐2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers. Cancer Invest 2005;23(8):653–9.Cross Ref linkPubmed link , , , et al.
- 117 Pegylated liposomal doxorubicin as second‐line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study. Cancer 2008;112(5):1147–52.Cross Ref linkPubmed link , , , et al.
- 118 Activity and safety of pegylated liposomal doxorubicin as first‐line therapy in the treatment of non‐visceral classic Kaposi's sarcoma: a multicenter study. J Invest Dermatol 2008;128(6):1578–80.Cross Ref linkPubmed link , , , et al.
- 119 Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review. Int J Immunopathol Pharmacol 2006;19(2):253–63.Pubmed link , , , .
- 120 Low to moderate cumulative doses of pegylated liposomal doxorubicin in the treatment of classic Kaposi sarcoma in elderly patients with comorbidities. Br J Dermatol 2008;158(2):431–2.Cross Ref linkPubmed link , , , et al.
- 121 Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease. Isr Med Assoc J 2001;3(4):251–3.Pubmed link , , , .
- 122 Treatment with taxanes of refractory or life‐threatening Kaposi sarcoma not associated with human immunodeficiency virus infection. Cancer 2006;106(8):1785–9.Cross Ref linkPubmed link , , , et al.
- 123 Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells. FEBS Lett 2007;581(30):5897–903.Cross Ref linkPubmed link , , , et al.
- 124 Imatinib‐induced regression of AIDS‐related Kaposi's sarcoma. J Clin Oncol 2005;23(5):982–9.Cross Ref linkPubmed link , , , et al.
- 125 A Kaposi's sarcoma complete clinical response after sorafenib administration. Ann Oncol 2008;19(9):1658–9.Cross Ref linkPubmed link , , , .